Literature DB >> 13887715

The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.

D J DRAIN, M HORLINGTON, R LAZARE, G A POULTER.   

Abstract

Entities:  

Keywords:  BRAIN/metabolism

Mesh：

Substances：

Year:  1962        PMID： 13887715     DOI： 10.1016/0024-3205(62)90035-8

Source DB:  PubMed          Journal:  Life Sci (1962)        ISSN： 0161-5564


× No keyword cloud information.
  5 in total

1.  Mast cells and monoamines.

Authors:  J Adams-Ray; A Dahlström; K Fuxe; N A Hillarp
Journal:  Experientia       Date:  1964-02-15

Review 2.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

3.  The biosynthesis of 5-hydroxytryptamine in brain.

Authors:  D G Grahame-Smith
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

4.  NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.

Authors:  H Nissbrandt; G Engberg; H Wikström; T Magnusson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

5.  A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.

Authors:  J W Commissiong; E M Sedgwick
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.